In this NEJM study, fremanezumab was effective as a preventive treatment for chronic migraine: http://ift.tt/2k9DoB2
Friday 29 December 2017
Fremanezumab for Preventive Treatment of Migraine
Fremanezumab is a humanized monoclonal antibody targeting calcitonin gene–related peptide (CGRP). It is administered monthly via SQ injection.
In this NEJM study, fremanezumab was effective as a preventive treatment for chronic migraine: http://ift.tt/2k9DoB2
via CasesBlog - Medical and Health Blog More READ
Lake forest health and fitness http://ift.tt/2zKEuFf
In this NEJM study, fremanezumab was effective as a preventive treatment for chronic migraine: http://ift.tt/2k9DoB2
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment